Pag-aaral pangklinika para sa Fatigue sa California
6 pag-aaral para sa Fatigue ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UC San Diego Medical Center - Encinitas, Encinitas
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
- at 14 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06989437A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Stanford Center for Sleep Medicine, Redwood City
- Trial Site Solutions, San Ramon
- Santa Monica Clinical Trials, Santa Monica
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Los Angeles
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- West Coast Pulmonary & Sleep Disorders Center, Lancaster
- Santa Monica Clinical Trials, Los Angeles
- Stanford Center for Sleep Sciences and Medicine, Redwood City
- at 2 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07675135Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study
- UCI Health Susan Samueli Integrative Health Institute, Irvine
- UCI Health, Orange
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT07581080Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
Nagre-recruitPhase 2
Edad 21 hanggang 85 · Lahat ng kasarian · Na-update May 6, 2026 · NCT04984226Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.